Pasar al contenido principal

IDENTIFICACION Y CARACTERIZACION DE BIOMOLECULAS EN LA SALIVA DE GARRAPATAS Y MECANISMOS ASOCIADOS CON LA RESPUESTA INMUNE FRENTE A ALPHA-GAL

PID2020-116761GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 35
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of tick salivary gland and saliva alphagalactome reveals candidate alpha-gal syndrome disease biomarkers

  • Villar, Margarita
  • Pacheco, Iván
  • Mateos-Hernández, Lourdes
  • Cabezas-Cruz, Alejandro
  • Tabor, Ala
  • Rodríguez-Valle, Manuel
  • Mulenga, Albert
  • Kocan, Katherine M.
  • Blouin, Edmour F.
  • Fuente, José de la
[Background]: Ticks are obligate hematophagous arthropods that synthesize the glycan Galα1-3Galβ1-(3)4GlcNAc-R (α-Gal) associated with the alpha-gal syndrome (AGS) or allergy to mammalian meat consumption., [Research design and methods]: In this study, we used a proteomics approach to characterize tick proteins in salivary glands (sialome SG), secreted saliva (sialome SA) and with α-Gal modification (alphagalactome SG and SA) in model tick species associated with the AGS in the United States (Amblyomma americanum) and Australia (Ixodes holocyclus). Selected proteins reactive to sera (IgE) from patients with AGS were identified to advance in the identification of possible proteins associated with the AGS. For comparative analysis, the α-Gal content was measured in various tick species., [Results]: The results confirmed that ticks produce proteins with α-Gal modifications and secreted into saliva during feeding. Proteins identified in tick alphagalactome SA by sera from patients with severe AGS symptomatology may constitute candidate disease biomarkers., [Conclusions]: The results support the presence of tick-derived proteins with α-Gal modifications in the saliva with potential implications in AGS and other disorders and protective capacity against tick infestations and pathogen infection. Future research should focus on the characterization of the function of tick glycoproteins with α-Gal in tick biology and AGS., This work was supported by the State Research Agency, Spain, project BIOGAL [PID2020-116761GB-I00], the Spanish Research Council Grant [2020AEP123] and Consejería de Educación, Cultura y Deportes, JCCM, Spain, project CCM17-PIC-036 (SBPLY/17/180501/000185). Ixodes holocyclus saliva and salivary gland collections was supported by the Australian Research Council Linkage Grant [LP120200836 (2013-2018)]. MV was supported by the University of Castilla La Mancha, UCLM, Spain, and the Fondo Europeo de Desarrollo Regional, FEDER, EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional characterization of α-Gal producing lactic acid bacteria with potential probiotic properties

  • Bamgbose, Timothy
  • Alberdi, Pilar
  • Abdullahi, Isa O.
  • Inabo, Helen I.
  • Bello, Mohammed
  • Sinha, Swati
  • Anvikar, Anupkumar R.
  • Mateos-Hernández, Lourdes
  • Torres-Maravilla, Edgar
  • Bermúdez-Humarán, Luis G.
  • Cabezas-Cruz, Alejandro
  • Fuente, José de la
The possibility of exploiting the human immune response to glycan α-Gal for the control of multiple infectious diseases has been the objective of recent investigations. In this field of research, the strain of Escherichia coli O86:B7 has been at the forefront, but this Gram-negative microorganism presents a safety concern and therefore cannot be considered as a probiotic. To address this challenge, this study explored the identification of novel lactic acid bacteria with a safe history of use, producing α-Gal and having probiotic potential. The lactic acid bacteria were isolated from different traditionally fermented foods (kununn-zaki, kindirmo, and pulque) and were screened for the production of α-Gal and some specific probiotic potential indicators. The results showed that Ten (10) out of forty (40) [25%] of the tested lactic acid bacteria (LAB) produced α-Gal and were identified as Limosilactobacillus fermentum, Levilactobacillus brevis, Agrilactobacillus composti, Lacticaseibacillus paracasei, Leuconostoc mesenteroides and Weissella confusa. Four (4) LAB strains with highest levels of α-Gal were further selected for in vivo study using a mouse model (α1,3GT KO mice) to elucidate the immunological response to α-Gal. The level of anti-α-Gal IgG observed were not significant while the level of anti-α-Gal IgM was lower in comparison to the level elicited by E. coli O86:B7. We concluded that the lactic acid bacteria in this study producing α-Gal have potential probiotic capacity and can be further explored in α-Gal-focused research for both the prevention and treatment of various infectious diseases and probiotic development., Research on α-Gal has been partially supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761 GB-I00). BT was supported by The World Academy of Sciences, Italy (FR number_3240306342) and the Department of Biotechnology, Government of India (BT/AB/03/04/2002Timothy)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Art–science multidisciplinary collaborations to address the scientific challenges posed by COVID-19

  • Fuente, José de la
The ongoing coronavirus pandemic COVID-19 constitutes a scientific and social challenge. The application of mixed-methods research with multidisciplinary collaborations increases the success of experimental design and interpretation of results to approach scientific challenges. The objective is to develop and implement protean art algorithms with interactions between artists and scientists for scientific research in areas of molecular biology, immunology, ecology and biomedicine. In this perspective, artists were invited to contribute pieces related to the pandemic, and scientists were then challenged to contribute their view and proposed research inspired by artist contribution to face COVID-19 scientific challenges. Proposed research objectives inspired by artist contributions contribute to approach COVID-19 scientific and social challenges with results that may translate into new diagnosis and control interventions. The proposed research objectives approach vaccine protective mechanisms and the development of nutritional interventions with possible impact on boosting protective response to vaccination, the impact of fuel pollutants on host immunity and virus transmission, the possible role of ectoparasite vectors in the appearance of SARS-CoV-2 variants and virus transmission, collaboration between different sectors to contribute to virus surveillance and reduce risks of contagion, characterization of the incidence of zoonotic diseases during and after the COVID-19 pandemic in relation to modifications in the interactions between humans and reservoir animal species, evaluation of the risks associated with sexual or congenital transmission of SARS-CoV-2, development of new methods for the easy and rapid detection of very low SARS-CoV-2 virus amounts in infected but asymptomatic individuals, and understanding society perceptions about the socio-ecological relationships between decoupled environments and the risks and effects of pandemics. This approach may be used to promote social participation in science through combined scientific and artistic perspectives with impact on science and society., Part of the reported ongoing studies related to alpha-Gal are supported by the Ministerio de Ciencia e Innovacion/Agencia Estatal de Investigacion MCIN/AEI/10.13039/ 501100011033, Spain and EU-FEDER [Grant BIOGAL PID2020-116761GB-I00]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Correlates with vaccine protective capacity and COVID-19 disease symptoms identified by serum proteomics in vaccinated individuals

  • Villar, Margarita
  • Urra, José Miguel
  • Artigas-Jerónimo, Sara
  • Mazuecos, Lorena
  • Contreras, Marinela
  • Vaz Rodrigues, Rita
  • Rodríguez del‐Río, Francisco J.
  • Gortázar, Christian
  • Fuente, José de la
This article belongs to the Special Issue Potential Anti-SARS-CoV-2 Molecular Strategies., In the last two years, the coronavirus disease 19 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a scientific and social challenge worldwide. Vaccines have been the most effective intervention for reducing virus transmission and disease severity. However, genetic virus variants are still circulating among vaccinated individuals with different disease symptomatology. Understanding the protective- or disease-associated mechanisms in vaccinated individuals is relevant to advances in vaccine development and implementation. To address this objective, serum-protein profiles were characterized by quantitative proteomics and data-analysis algorithms in four cohorts of uninfected and SARS-CoV-2-infected vaccinated individuals with asymptomatic, non-severe, and severe disease symptomatology. The results show that immunoglobulins were the most overrepresented proteins in infected cohorts when compared to PCR-negative individuals. The immunoglobulin profile varied between different infected cohorts and correlated with protective- or disease-associated capacity. Overrepresented immunoglobulins in PCR-positive individuals correlated with protective response against SARS-CoV-2, other viruses, and thrombosis in asymptomatic cases. In non-severe cases, correlates of protection against SARS-CoV-2 and HBV together with risk of myasthenia gravis and allergy and autoantibodies were observed. Patients with severe symptoms presented risk for allergy, chronic idiopathic thrombocytopenic purpura, and autoantibodies. The analysis of underrepresented immunoglobulins in PCR-positive compared to PCR-negative individuals identified vaccine-induced protective epitopes in various coronavirus proteins, including the spike receptor-binding domain RBD. Non-immunoglobulin proteins were associated with COVID-19 symptoms and biological processes. These results evidence host-associated differences in response to vaccination and the possibility of improving vaccine efficacy against SARS-CoV-2., This research was funded by the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain, and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00); and the Junta de Comunidades de vncha (JCCM), Spain, and EU-FEDER (grant MYCOTRAINING SBPLY/19/180501/000174)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Additional considerations for anti-tick vaccine research

  • Fuente, José de la
  • Contreras, Marinela
The part of the research included in this paper was supported by the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00) and the Consejería de Educación, Cultura y Deportes, JCCM, Spain, project CCM17-PIC-036 (SBPLY/17/180501/000185)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Current and future strategies for the diagnosis and treatment of the Alpha-Gal Syndrome (AGS)

  • Vaz Rodrigues, Rita
  • Mazuecos, Lorena
  • Fuente, José de la
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed anaphylaxis in foods containing the oligosaccharide galactose-α-1,3-galactose (α-Gal) such as mammalian meat or dairy products. Clinical presentation of AGS can also comprise immediate hypersensitivity due to anticancer therapy, gelatin-containing vaccines or mammalian serum-based antivenom. The IgE initial sensitization is caused by hard-bodied tick bites and symptomatic individuals typically develop delayed pruritus, urticaria, angioedema, anaphylaxis, malaise or gut-related symptoms. Due to inapparent presentation, delayed reactions and a wide variety of patients´ clinical history, the AGS diagnosis and treatment remain challenging. This review covers not only current diagnostic methods used for AGS such as the skin prick test (SPT), the oral food challenge (OFC), anti-α-Gal IgE levels measurement and the basophil activation test (BAT), but also potentially relevant next-generation diagnostic tools like the mast cell activation test (MAT), the histamine-release (HR) assay, omics technologies and model-based reasoning (MBR). Moreover, it focuses on the therapeutical medical and non-medical methods available and current research methods that are being applied in order to elucidate the molecular, physiological and immune mechanisms underlying this allergic disorder. Lastly, future treatment and preventive tools are also discussed, being of utmost importance for the identification of tick salivary molecules, with or without α-Gal modifications, that trigger IgE sensitivity as they could be the key for further vaccine development. Bearing in mind climate change, the tick-host paradigm will shift towards an increasing number of AGS cases in new regions worldwide, which will pose new challenges for clinicians in the future., Research on AGS was funded by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/ 10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00). R. Vaz-Rodrigues was supported by a doctoral contract (2022/20675) from Universidad de Castilla-La Mancha (UCLM), Spain, co-financed by the European Social Fund (ESF). L. Mazuecos was supported by a post-doctoral grant (2021-POST-32002) from UCLM co-financed by ESF., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations

  • Kasaija, Paul D.
  • Contreras, Marinela
  • Kabi, Fredrick
  • Mugerwa, Swidiq
  • Garrido, Joseba M.
  • Gortázar, Christian
  • Fuente, José de la
Tick vaccines are necessary as part of a One Health approach for the control of tick infestations and tick-borne diseases. Subolesin (SUB, also known as 4D8) is a tick protective antigen that has shown efficacy in vaccine formulations for the control of ectoparasite infestations and pathogen infection/transmission. A recent proof-of-concept study reported oral vaccination combining Rhipicephalus microplus SUB with heat inactivated Mycobacterium bovis (IV) as an immunostimulant for the control of cattle tick infestations. Based on the efficacy of Rhipicephalus decoloratus SUB for the control of multiple cattle tick species in Uganda, herein we design a controlled pen trial using an oral formulation combining R. decoloratus SUB with IV for the control of R. decoloratus and Rhipicephalus appendiculatus cattle tick infestations. Vaccine efficacy (E) of SUB + IV on tick life cycle was compared with IV and SUB alone and with PBS as control. The IgG antibody titers against SUB and M. bovis P22 and the serum levels of selected protein immune biomarkers (IL-1beta, TNF-alpha, C3) were determined and analyzed as possible correlates of protection. Oral immunization with IV and SUB alone and in SUB + IV combination were effective for the control of tick infestations (E = 71–96% for R. decoloratus and 87–99% for R. appendiculatus) with highest E (higher than 95%) for SUB + IV. The results demonstrated that oral immunization with the SUB + IV formulation resulted in effective control of cattle tick infestations through the activation of multiple immune mechanisms. These results support the application of oral vaccine formulations with SUB + IV for the control of cattle infestations with Rhipicephalus species towards improving animal health., This research was financially supported by the National Agricultural Research Organization (NARO) of Uganda. The IV research was also funded by Junta de Castilla-La Mancha, Spain, project MYCOTRAINING SBPLY/19/180501/000174 and the State Research Agency, Spain, project BIOGAL [PID2020-116761 GB-I00]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Heat inactivated mycobacteria, alpha-gal and zebra fish: insights gained from experiences with two promising trained immunity inductors and a validated animal model

  • Juste, Ramón A.
  • Ferreras-Colino, Elisa
  • Fuente, José de la
  • Domínguez, Mercedes
  • Risalde, María Ángeles
  • Domínguez, Lucas
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
Trained immunity (TRAIM) may be defined as a form of memory where innate immune cells such as monocytes, macrophages, dendritic and natural killer (NK) cells undergo an epigenetic reprogramming that enhances their primary defensive capabilities. Cross-pathogen protective TRAIM can be triggered in different hosts by exposure to live microbes or microbe-derived products such as heat-inactivated Mycobacterium bovis or with the glycan α-Gal to elicit protective responses against several pathogens. We review the TRAIM paradigm using two models representing distinct scales of immune sensitization: the whole bacterial cell and one of its building blocks, the polysaccharides or glycans. Observations point out to macrophage lytic capabilities and cytokine regulation as two key components in non-specific innate immune responses against infections. The study of the TRAIM response deserves attention to better characterize the evolution of host–pathogen cooperation both for identifying the aetiology of some diseases and for finding new therapeutic strategies. In this field, the zebrafish provides a convenient and complete biological system that could help to deepen in the knowledge of TRAIM-mediated mechanisms in pathogen–host interactions., European Regional Development Fund, Grant/Award Number: BIOGAL PID2020-116761GB-I00; Gobierno del Principado de Asturias, Grant/Award Number: PCTI 2021-2023 (GRUPIN: IDI2021-000102; Junta de Comunidades de Castilla-La Mancha, Grant/Award Numbers: CCM17-PIC-036 (SBPLY/17/180501/000185), MYCOTRAINING SBPLY/19/180501/000174; Ministerio de Ciencia e Innovación, Grant/Award Number: MCIN/AEI/10.13039/501100011033; Universidad de Castilla-La Mancha, Grant/Award Number: 2020/3836, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Low NETosis induced in Anaplasma phagocitophilum-infected cells

  • Artigas-Jerónimo, Sara
  • González-García, Almudena
  • Fuente, José de la
  • Blanda, Valeria
  • Shekarkar Azgomi, Mojtaba
  • Villar, Margarita
  • Mohammadnezhad, Leila
  • Grippi, Francesca
  • Torina, Alessandra
  • Sireci, Guido
This article belongs to the Special Issue The Innate Immune Defense of Animals Living in Pathogenic Environments., Anaplasma phagocytophilum are obligatory intracellular bacteria that preferentially replicate inside leukocytes by utilizing biological compounds and processes of these primary host defensive cells. In this study, bioinformatics analysis was conducted to further characterize A. phagocytophilum–host interactions using the neutrophil-like model of human Caucasian promyelocytic leukemia HL60 cells. We detected a hierarchy of molecules involved in A. phagocytophilum-HL60 interactions with overrepresentation in infected human cells of proteins involved in the reactive oxygen species (ROS) pathway and cell surface monocyte markers. As A. phagocytophilum phagocytosis by neutrophils is inhibited, the results suggested a possible explanation for our bioinformatics data: radical oxygen compounds could induce the killing of bacteria activating NETosis, a unique form of defense mechanism resulting in cell death that is characterized by the release of decondensed chromatin and granular contents to the extracellular space, forming neutrophil extracellular traps (NETs) to eliminate invading microorganisms. Thus, we confirmed the existence of a low NETosis induced in A. phagocytophilum-infected cells by immunofluorescence (IF) experiments. These results provide new insights into the complex mechanisms that govern immune response during A. phagocytophilum host interactions., The study was supported by the Italian Ministry of Health grants RC IZSSI 08/19 and RC IZSSI 01/20 and by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación, Spain and EU-FEDER [Grant BIOGAL PID2020-116761GB-I00]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Zebrafish animal model for the study of allergic reactions in response to tick saliva biomolecules

  • Contreras, Marinela
  • González-García, Almudena
  • Fuente, José de la
Ticks are arthropod vectors that cause disease by pathogen transmission and whose bites could be related to allergic reactions impacting human health worldwide. In some individuals, high levels of immunoglobulin E antibodies against the glycan Galα1-3Galβ1-(3)4GlcNAc-R (α-Gal) have been induced by tick bites. Anaphylactic reactions mediated by glycoproteins and glycolipids containing the glycan α-Gal, present in tick saliva, are related to alpha-Gal syndrome (AGS) or mammalian meat allergy. Zebrafish (Danio rerio) has become a widely used vertebrate model for the study of different pathologies. In this study, zebrafish was used as a model for the study of allergic reactions in response to α-Gal and mammalian meat consumption because, like humans, they do not synthesize this glycan. For this purpose, behavioral patterns and hemorrhagic anaphylactic-type allergic reactions in response to Ixodes ricinus tick saliva and mammalian meat consumption was evaluated. This experimental approach allows the obtention of valid data that support the zebrafish animal model for the study of tick-borne allergies including AGS., This work was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00). Marinela Contreras is funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant IJC2020-042710-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Serum biomarkers for nutritional status as predictors in COVID-19 patients before and after vaccination

  • Vaz Rodrigues, Rita
  • Mazuecos, Lorena
  • Villar, Margarita
  • Urra, José Miguel
  • Gortázar, Christian
  • Fuente, José de la
The aim of this study was to characterize serum protein biomarkers for nutritional status that may be used as predictors for disease symptomatology in COVID-19 patients before and after vaccination. In pre-vaccine cohorts, proteomics analysis revealed significant differences between groups, with serum proteins alpha-1-acid glycoproteins (AGPs) 1 and 2, C-reactive protein (CRP) and retinol binding protein (RBP) increasing with COVID-19 severity, in contrast with serum albumin, transthyretin (TTR) and serotransferrin (TF) reduction as the symptomatology increased. Immunoassay reproduced and validated proteomics results of serum proteins albumin and RBP. In post-vaccine cohorts, the results showed the same pattern as in pre-vaccine cohorts for serum proteins AGPs, CRP, albumin and TTR. However, TF levels were similar between groups and RBP presented a slight reduction as COVID-19 symptomatology increased. In these cohorts, immunoassay validated proteomics results of serum proteins albumin, TTR and TF. Additionally, immune response to α-Gal in pre-vaccine cohorts varied in predominant immunoglobulin type profile, while post-vaccine groups presented mainly anti-α-Gal protective IgG antibodies. The study identified serum nutritional biomarkers that could potentially predict an accurate prognostic of COVID-19 disease to provide an appropriate nutritional care and guidance in non-vaccinated and vaccinated individuals against SARS-CoV-2. These results highlight the importance of designing personalized nutrition protocols to improve diet along with the application of prebiotics or probiotics for the control of COVID-19 and other infectious diseases., This study was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación, Spain and EU-FEDER [Grant BIOGAL PID2020-116761 GB-I00]. RV-R was funded by Universidad de Castilla-La Mancha (UCLM), Spain and the European Social Fund (ESF) [grant 2022-PRED-20675]. LM was supported by UCLM and the ESF [grant 2021-POST-32002]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antibody isotype epitope mapping of SARS-CoV-2 Spike RBD protein: Targets for COVID-19 symptomatology and disease control

  • Contreras, Marinela
  • Vicente, Joaquín
  • Cerón, José J.
  • Martínez-Subiela, Silvia
  • Urra, José Miguel
  • Rodríguez del‐Río, Francisco J.
  • Ferreras-Colino, Elisa
  • Vaz Rodrigues, Rita
  • Fernández de Mera, Isabel G.
  • Antunes, Sandra
  • Domingos, Ana
  • Gortázar, Christian
  • Fuente, José de la
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still poses a challenge for biomedicine and public health. To advance the development of effective diagnostic, prognostic, and preventive interventions, our study focused on high-throughput antibody binding epitope mapping of the SARS-CoV-2 spike RBD protein by IgA, IgM and IgG antibodies in saliva and sera of different cohorts from healthy uninfected individuals to SARS-CoV-2-infected unvaccinated and vaccinated asymptomatic, recovered, nonsevere, and severe patients. Identified candidate diagnostic (455-LFRKSNLKPFERD-467), prognostic (395-VYADSFVIRGDEV-407-C-KLH, 332-ITNLCPFGEV-342-C-KLH, 352-AWNRKRI-358-C-KLH, 524-VCGPKKSTNLVKN-536-KLH), and protective (MKLLE-487-NCYFPLQSYGFQPTNGVG-504-GGGGS-446-GGNYNYLYRLFRKSNLKPFERD-467) epitopes were validated with sera from prevaccine and postvaccine cohorts. The results identified neutralizing epitopes and support that antibody recognition of linear B-cell epitopes in RBD protein is associated with antibody isotype and disease symptomatology. The findings in asymptomatic individuals suggest a role for anti-RBD antibodies in the protective response against SARS-CoV-2. The possibility of translating results into diagnostic interventions for the early diagnosis of asymptomatic individuals and prognosis of disease severity provides new tools for COVID-19 surveillance and evaluation of risks in hospitalized patients. These results, together with other approaches, may contribute to the development of new vaccines for the control of COVID-19 and other coronavirus-related diseases using a quantum vaccinomics approach through the combination of protective epitopes., This study was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación, Spain and EU-FEDER [Grant BIOGAL PID2020-116761GB-I00]. M.C. was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant IJC2020-042710-I. RV-R was funded by Universidad de Castilla-La Mancha (UCLM), Spain and the European Social Fund (ESF) [grant 2022-PRED-20675]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Quantum vaccinomics platforms to advance in vaccinology

  • Fuente, José de la
  • Contreras, Marinela
The opinion flows from Introduction to the immunological quantum that requires a historical perspective, to Quantum vaccine algorithms supported by a bibliometric analysis, to Quantum vaccinomics describing from our perspective the different vaccinomics and quantum vaccinomics algorithms. Finally, in the Discussion and conclusions we propose novel platforms and algorithms developed to further advance on quantum vaccinomics. In the paper we refer to protective epitopes or immunological quantum for the design of candidate vaccine antigens, which may elicit a protective response through both cellular and antibody mediated mechanisms of the host immune system. Vaccines are key interventions for the prevention and control of infectious diseases affecting humans and animals worldwide. Biophysics led to quantum biology and quantum immunology reflecting quantum dynamics within living systems and their evolution. In analogy to quantum of light, immune protective epitopes were proposed as the immunological quantum. Multiple quantum vaccine algorithms were developed based on omics and other technologies. Quantum vaccinomics is the methodological approach with different platforms used for the identification and combination of immunological quantum for vaccine development. Current quantum vaccinomics platforms include in vitro, in music and in silico algorithms and top trends in biotechnology for the identification, characterization and combination of candidate protective epitopes. These platforms have been applied to different infectious diseases and in the future should target prevalent and emerging infectious diseases with novel algorithms., This work was supported in part by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00). MC is funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (Grant IJC2020-042710-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Allergic reactions associated with medically relevant arthropods

  • Vaz Rodrigues, Rita
  • Feo Brito, Francisco
  • Guzmán Rodríguez, Raúl
  • Mazuecos, Lorena
  • Fuente, José de la
[Objective]: Vector-borne diseases are a growing burden worldwide. In particular, the risks of allergic reactions to bites are associated with growing arthropod populations in contact with the public. The diversity of allergic reactions associated with host and arthropod factors difficult disease diagnosis, prognosis and prevention. Therefore, arthropod-associated allergies are underdiagnosed and require better surveillance of arthropod populations and disease diagnosis and management., [Methods]: To face these challenges, in this study, we describe five cases to illustrate arthropod-associated allergies with different symptomatology, including alpha-gal syndrome (AGS) associated with anti-alpha-gal IgE antibody titres. Information on symptoms in response to arthropod bites was collected from patients and medical doctors., [Results]: The five cases included patients bitten by a robber fly and different tick species. Cases were in Spain or U.S.A. Two cases were diagnosed with AGS and one case was diagnosed with anaphylaxis in response to tick bite with high anti-alpha-gal IgE levels. The symptoms in response to arthropod bites vary between different cases., [Conclusion]: Allergic reactions and symptoms in response to arthropod bites vary in association with host and arthropod factors. Herein we propose recommendations to control allergic symptoms, associated disease risk factors and the way forward to advance in the prevention and control of arthropod-associated allergies., The submitted work was partially supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00). R. Vaz-Rodrigues was supported by a doctoral contract (2022/20675), from Universidad de Castilla-La Mancha (UCLM), Spain, co-financed by the European Social Fund (ESF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Allergic reactions to tick saliva components in zebrafish model

  • Contreras, Marinela
  • Vaz Rodrigues, Rita
  • Mazuecos, Lorena
  • Villar, Margarita
  • Artigas-Jerónimo, Sara
  • González-García, Almudena
  • Shilova, Nadezhda V.
  • Bovin, Nicolai V.
  • Díaz-Sánchez, Sandra
  • Ferreras-Colino, Elisa
  • Pacheco, Iván
  • Chmelař, Jindrǐch
  • Kopáček, Petr
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
  • Fuente, José de la
[Background]: Alpha-Gal syndrome (AGS) is a tick-borne food allergy caused by IgE antibodies against the glycan galactose-alpha-1,3-galactose (α-Gal) present in glycoproteins and glycolipids from mammalian meat. To advance in the diagnosis and treatment of AGS, further research is needed to unravel the molecular and immune mechanisms underlying this syndrome. The objective of this study is the characterization of tick salivary components and proteins with and without α-Gal modifications involved in modulating human immune response against this carbohydrate., [Methods]: Protein and α-Gal content were determined in tick saliva components, and proteins were identified by proteomics analysis of tick saliva fractions. Pathophysiological changes were recorded in the zebrafish (Danio rerio) model after exposure to distinct Ixodes ricinus tick salivary components. Serum samples were collected from zebrafish at day 8 of exposure to determine anti-α-Gal, anti-glycan, and anti-tick saliva protein IgM antibody titers by enzyme-linked immunosorbent assay (ELISA)., [Results]: Zebrafish treated with tick saliva and saliva protein fractions combined with non-protein fractions demonstrated significantly higher incidence of hemorrhagic type allergic reactions, abnormal behavioral patterns, or mortality when compared to the phosphate-buffered saline (PBS)-treated control group. The main tick salivary proteins identified in these fractions with possible functional implication in AGS were the secreted protein B7P208-salivary antigen p23 and metalloproteases. Anti-α-Gal and anti-tick salivary gland IgM antibody titers were significantly higher in distinct saliva protein fractions and deglycosylated saliva group when compared with PBS-treated controls. Anti-glycan antibodies showed group-related profiles., [Conclusions]: Results support the hypothesis that tick salivary biomolecules with and without α-Gal modifications are involved in modulating immune response against this carbohydrate., This study was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00). M. Contreras was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant IJC2020-042710-I. R. Vaz-Rodrigues was supported by a doctoral contract (2022/20675), from Universidad de Castilla-La Mancha (UCLM), Spain, co-financed by the European Social Fund (ESF). L. Mazuecos was supported by UCLM co-financed by ESF, post-doctoral grant 2021/32002). E. Ferreras-Colino was funded by UCLM co-financed by ESF, doctoral grant 2020/3836., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Citizen science on Lyme Borreliosis in Spain reveals disease-associated risk factors and control interventions

  • Fuente, José de la
  • Estrada-Peña, Agustín
  • Gortázar, Christian
  • Vaz Rodrigues, Rita
  • Sánchez, Isabel
  • Carrión Tudela, Juan
[Background]: Lyme borreliosis (LB) caused by Borrelia burgdorferi sensu lato complex spirochetes is one of the tick-borne diseases with high prevalence and social/economic burden in the United States, Spain, and other European countries. The objective is to address limited information available about the incidence, prevalence, and symptoms of LB, current prevention, and treatment interventions that are not adequately focused and thus not very effective against this disease., [Methods]: To address these limitations, in this study, we used a citizen science approach to evaluate the LB-associated risks and implementation of control interventions in Spain. A total of 405 participants in the survey were included in the analysis. Responses to the questionnaire were received during January-July 2022. The questionnaire contained qualitative and quantitative questions. Homogeneity among binary variables was analyzed using a Fisher's exact test., [Results]: Despite limitations of the study associated with response to the questionnaire and information on tick species, the results evidenced the effect of factors such as age, gender, tick bites, disease clinical signs, comorbidities such as alpha-gal syndrome, health care services, and treatment effectiveness affecting LB., [Conclusions]: The main conclusions of the study highlight the need for better surveillance of tick infestations, pathogen infection, and diagnosis of LB and related comorbidities. To advance in disease prevention, diagnosis, and treatment, new interventions need to be developed and implemented in both public and private health care services. Providing access to these results to the society, health care system, and scientists is important to further advance in disease surveillance, diagnosis, control, and prevention., This study was partially supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación, Spain, and EU-FEDER [grant BIOGAL number PID2020-116761GB-I00]. R.V.-R. was funded by Universidad de Castilla-La Mancha (UCLM), Spain, and the European Social Fund (ESF) [grant no. 2022-PRED-20675]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Frankenbacteriosis targeting interactions between pathogen and symbiont to control infection in the tick vector

  • Mazuecos, Lorena
  • Alberdi, Pilar
  • Hernández-Jarguín, Angélica
  • Contreras, Marinela
  • Villar, Margarita
  • Cabezas-Cruz, Alejandro
  • Šimo, Ladislav
  • González-García, Almudena
  • Díaz-Sánchez, Sandra
  • Neelakanta, Girish
  • Bonnet, Sarah I.
  • Fikrig, Erol
  • Fuente, José de la
Tick microbiota can be targeted for the control of tick-borne diseases such as human granulocytic anaplasmosis (HGA) caused by model pathogen, Anaplasma phagocytophilum. Frankenbacteriosis is inspired by Frankenstein and defined here as paratransgenesis of tick symbiotic/commensal bacteria to mimic and compete with tick-borne pathogens. Interactions between A. phagocytophilum and symbiotic Sphingomonas identified by metaproteomics analysis in Ixodes scapularis midgut showed competition between both bacteria. Consequently, Sphingomonas was selected for frankenbacteriosis for the control of A. phagocytophilum infection and transmission. The results showed that Franken Sphingomonas producing A. phagocytophilum major surface protein 4 (MSP4) mimic pathogen and reduce infection in ticks by competition and interaction with cell receptor components of infection. Franken Sphingomonas-MSP4 transovarial and trans-stadial transmission suggests that tick larvae with genetically modified Franken Sphingomonas-MSP4 could be produced in the laboratory and released in the field to compete and replace the wildtype populations with associated reduction in pathogen infection/transmission and HGA disease risks., This study was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de InvestigaciónMCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (GrantBIOGAL PID2020-116761GB-I00). M. Contreras was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grantIJC2020-042710-I. L. Mazuecos was supported by a postdoctoral grant (2021/32002) from UCLM co-financed by the European Social Fund (ESF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic modification, characterization, and co-infection of Franken Sphingomonas and Anaplasma phagocytophilum in tick cells

  • Mazuecos, Lorena
  • González-García, Almudena
  • Fuente, José de la
Paratransgenesis through genetic manipulation of symbiotic or commensal microorganisms has been proposed as an effective and environmentally sound approach for the control of vector-borne diseases, including tick bite-related pathologies, and reducing pathogen transmission. Here, we present a protocol for Sphingomonas transformation with Anaplasma phagocytophilum major surface protein 4 and heat shock protein 70. We describe a step-by-step protocol for in vitro study of interactions between transformed Franken Sphingomonas and Ixodes scapularis ISE6 tick cells during A. phagocytophilum infection., This study was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (grant BIOGAL PID2020-116761GB-I00). L.M. was supported by a postdoctoral grant (2021/32002) from UCLM co-financed by the European Social Fund (ESF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Innovative approaches for the control of ticks and tick-borne diseases

  • Fuente, José de la
  • Mazuecos, Lorena
  • Contreras, Marinela
The authors thank our SaBio group members, colleagues meeting at the 15th International Symposium on Ticks and Tick-borne Diseases (29–31 March 2023, Weimar, Germany) and A. Cabezas-Cruz, G. Neelakanta, and E. Fikrig for fruitful discussions, feedback, and collaboration., Ticks and tick-borne diseases constitute a major threat for human and animal health worldwide. Vaccines for the control of tick infestations and transmitted pathogens still represents a challenge for science and health. Vaccines have evolved with antigens derived from inactivated pathogens to recombinant proteins and vaccinomics approaches. Recently, vaccines for the control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown the efficacy of new antigen delivery platforms. However, until now only two vaccines based on recombinant Bm86/Bm95 antigens have been registered and commercialized for the control of cattle-tick infestations. Nevertheless, recently new technologies and approaches are under consideration for vaccine development for the control of ticks and tick-borne pathogens. Genetic manipulation of tick commensal bacteria converted enemies into friends. Frankenbacteriosis was used to control tick pathogen infection. Based on these results, the way forward is to develop new paratransgenic interventions and vaccine delivery platforms for the control of tick-borne diseases., We are supported in part by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020–116761GB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multi-omics analysis of zebrafish response to tick saliva reveals biological processes associated with alpha-Gal syndrome

  • Vaz Rodrigues, Rita
  • Mazuecos, Lorena
  • Villar, Margarita
  • Contreras, Marinela
  • Artigas-Jerónimo, Sara
  • González-García, Almudena
  • Gortázar, Christian
  • Fuente, José de la
The alpha-Gal syndrome (AGS) is a tick-borne allergy. A multi-omics approach was used to determine the effect of tick saliva and mammalian meat consumption on zebrafish gut transcriptome and proteome. Bioinformatics analysis using R software was focused on significant biological and metabolic pathway changes associated with AGS. Ortholog mapping identified highly concordant human ortholog genes for the detection of disease-enriched pathways. Tick saliva treatment increased zebrafish mortality, incidence of hemorrhagic type allergic reactions and changes in behavior and feeding patterns. Transcriptomics analysis showed downregulation of biological and metabolic pathways correlated with anti-alpha-Gal IgE and allergic reactions to tick saliva affecting blood circulation, cardiac and vascular smooth muscle contraction, behavior and sensory perception. Disease enrichment analysis revealed downregulated orthologous genes associated with human disorders affecting nervous, musculoskeletal, and cardiovascular systems. Proteomics analysis revealed suppression of pathways associated with immune system production of reactive oxygen species and cardiac muscle contraction. Underrepresented proteins were mainly linked to nervous and metabolic human disorders. Multi-omics data revealed inhibition of pathways associated with adrenergic signaling in cardiomyocytes, and heart and muscle contraction. Results identify tick saliva-related biological pathways supporting multisystemic organ involvement and linking α-Gal sensitization with other illnesses for the identification of potential disease biomarkers., This work was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/ 10.13039/501100011033, Spain and EU-FEDER [grant BIOGAL PID2020116761GB-I00]. R. Vaz-Rodrigues was funded by Universidad de Castilla-La Mancha (UCLM), Spain and the European Social Fund (ESF) [doctoral contract 2022-PRED-20675]. L. Mazuecos was supported by UCLM co-financed by ESF [post-doctoral grant 2021-POST-32002]. M. Contreras was funded by Ministerio de Ciencia, Innovación y Universidades, Spain [post-doctoral grant IJC2020-042710-I]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The alpha-Gal syndrome is underdiagnosed, El síndrome de alfa-Gal está infradiagnosticado

  • Fuente, José de la
Referred to by: [Artículo traducido] El síndrome de alfa-Gal está infradiagnosticado; Actas Dermo-Sifiliográficas, Volume 115, Issue 1, January 2024, Pages T116-T117; J. de la Fuente, Our research on AGS is supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (grant BIOGAL PID2020-116761GB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Las garrapatas y la alergia a la carne roja

  • Mazuecos, Lorena
  • Fuente, José de la
  • Villar, Margarita
Las garrapatas son ectoparásitos artrópodos que actúan como vectores de patógenos y causan reacciones alérgicas, afectando a la salud humana y animal en todo el mundo. En los seres humanos, sus picaduras pueden inducir altos niveles de anticuerpos IgE contra el carbohidrato alfa-Gal presente en biomoléculas de su saliva, que median reacciones alérgicas a sus picaduras y a la carne de mamíferos conocidas como síndrome alfa-Gal., Proyecto BIOGAL: Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a alfa-gal., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Vaccines for the control of cattle ticks in Uganda

  • Kasaija, Paul D.
Doctorado en Ciencias Agrarias y Ambientales., [Chapter I]: Ticks and tick-borne diseases have a negative impact on human and animal health worldwide. Ticks are the most important vectors of pathogen that cause economically important diseases in animals and affect human health and are widespread in Uganda due to the suitable climatic conditions. Traditional tick control methods are primarily based on the use of chemical acaricides, which can result in the selection of resistant ticks, environmental pollution, and contamination of milk and meat products with residues affecting in particular the cattle industry, resulting into economic losses., [General Introduction]: which describes the epidemiology of ticks and tick-borne diseases (TBDs) and their economic impact in Uganda. This chapter is a review paper [Kasaija, P.D., Estrada-Peña, A., Contreras, M., Kirunda, H., de la Fuente, J. (2021). Ticks and tick-borne diseases: a review of Uganda’s situation. Ticks and Tick-Borne Diseases 12, 101756] about how cattle are affected by TBDs. Due to the suitable climatic conditions, ticks are widespread in Uganda and cause over USD 1.1 billion of economics losses. Among the tick species in Uganda, the most economically important ticks are Rhipicephalus decoloratus, R. appendiculatus, and A. variegatum. In this country, exotic cattle breeds are more susceptible to ticks and the diseases they transmit than indigenous cattle, demanding intensive use of acaricides for tick control and prevention of TBDs. Consequently, the abusive use of these acaricides leads to the selection of acaricide-resistant tick populations. In this context, vaccination could be an effective alternative, that also integrated with tick control approaches that limit tick exposure, could disrupt the spread of ticks and TBDs., [Chapter II]: Design and evaluation of Subolesin-based vaccines for the control of cattle tick infestations in Uganda. Chapter I describes how vaccines are a feasible alternative to acaricide control of tick infestation in mammalian hosts. Immunization with recombinant SUB results in hosts (cattle) protection against infestation by decreasing tick survival and reproduction rates. The SUB protein sequences from the ticks R. decoloratus, R. appendiculatus, and A. variegatum from Uganda are highly homologous (75% amino acid identity), which explains the observed cross-protection [Kasaija, P.D., Contreras, M., Kabi, F., Mugerwa, S., de la Fuente, J. (2020). Vaccination with recombinant Subolesin antigens provides cross-tick species protection in Bos indicus and crossbred cattle in Uganda. Vaccines 8,319]. Cattle vaccination with SUB vaccine formulations induces sustained antigen-specific IgG production that affects various tick developmental stages with minor differences between tick species. The higher vaccine efficacy observed in crossbreed cattle reflects the influence of the host’s genotype on the immune response. Vaccination with a combination of SUB antigens from the different tick species produces limited vaccine efficacy. Nevertheless, study results suggest the possibility of using SUB-based antigens for the control of multiple tick species in different cattle breeds of Uganda. Additionally, in this chapter Quantum vaccinomics approach is used to identify B-cell reactive epitopes by mapping antigen peptides in a microarray using sera from vaccinated cattle. The reactive and conserved SUB peptides identified using epitope-mapping methods may have an influence on the vaccine efficacy and immunological protection observed and could thus constitute chimeric SUB antigens for production of cross-protective and personalised anti-tick vaccines [Contreras, M., Kasaija, P.D., Kabi, F., Mugerwa, S., de la Fuente, J. (2022). The correlation between Subolesin-reactive epitopes and vaccine efficacy. Vaccines 10, 1327.]., [Chapter III]: Design and evaluation of oral vaccine formulations based on Subolesin and heat inactivated mycobacteria immunostimulant for the control of cattle tick infestations in Uganda.In this chapter includes and optimization of vaccine formulations, including the possibility of oral administration to improve cattle welfare and safety. Orally administered SUB vaccine formulations, such as SUB+IV, improved vaccine delivery and safety. The SUB+IV vaccine antigens activate both the innate and adaptive immune pathways which improves overall vaccine efficacy [Contreras, M., Kasaija, P.D., Merino, O., de la Cruz-Hernandez, N.I., Gortazar, C., de la Fuente, J. (2019). Oral vaccination with a formulation combining R. microplus Subolesin with heat inactivated Mycobacterium bovis reduces tick infestations in cattle. Frontiers in Cellular and Infection Microbiology 9, 45]. In a second study including in this chapter, oral R. decoloratus SUB with IV vaccine formulation showed good results for controlling tick infestations of R. appendiculatus and R. decoloratus [Kasaija, P.D., Contreras, M., Kabi, F., Mugerwa, S., Garrido, J.M., Gortazar, C., de la Fuente, J. (2022). Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations. Vaccine 40,4564-4573]., [Chapter IV]: General discussion Chapter IV is presented as a general discussion with an overview of interventions and challenges for the control of ticks and tick-borne diseases in Uganda, being a priority for the Government of Uganda to promote economic growth in the country. A multidisciplinary approach to combining different control measures including cattle management and the rational use of acaricides and the development and application of anti-tick vaccines are proposed in this chapter. In addition, collaboration between research institutions specialized in these areas with those located in the affected countries is necessary to achieve these goals [de la Fuente, J., Contreras, M., Kasaija, P.D., Gortázar, C., Ruiz-Fons, J.F., Mateo, R., Kabi, F. (2019). Towards a multidisciplinary approach to improve cattle health and production in Uganda. Vaccines 7: 165]. As an example of these approaches and collaborations this chapter also includes a collaboration program that was established between the group of Health and Biotechnology (SaBio) of the IREC Institute of Game and Wildlife Research (CSIC-UCLM-JCCM, Spain) and the National Agricultural Research Organization of Uganda (NARO) for the development of vaccines for the control of cattle ticks in Uganda. In this context, a controlled pen trials identified a tick protective antigen, R. appendiculatus SUB, and a cross-species-effective vaccine formulation was designed and exposed in this chapter [Kabi, F., Dhikusooka, M., Matovu, M., Mugerwa, S., Kasaija, P., Emudong, P., Kirunda, H., Contreras, M., Gortázar, C., de la Fuente, J. (2022). Monitoring the Subolesin vaccine field trial for safer control of cattle ticks amidst increasing acaricide resistance in Uganda. Vaccines 10: 1594]., The realization of this research work has been made possible by the financial support of the following entities and projects: This research was financially supported by the Ministerio de Economía, Industria y Competitividad (Spain) grant BFU2016-79892-P. Junta de Castilla-La Mancha, Spain, project MYCOTRAINING SBPLY/19/180501/000174. State Research Agency, Spain, project BIOGAL [PID2020-116761 GB-I00]. National Agricultural Research Organization (NARO). Consejo Superior de Investigaciones Científicas., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Catastrophic selection: the other side of the coin

  • Fuente, José de la
Recently, a machine learning molecular de-extinction paleoproteomic approach was used to recover inactivated antimicrobial peptides to overcome the challenges posed by antibiotic-resistant pathogens. The authors showed the possibility of identifying lost molecules with antibacterial capacity, but the other side of the coin associated with catastrophic selection should be considered for the development of new pharmaceuticals., The study of AGS is supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER [grant BIOGAL PID2020-116761GB-I00]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Design and evaluation of vaccines for the control of the etiological agent of East Coast fever

  • Fuente, José de la
  • Sobrino, Isidro
  • Villar, Margarita
East Coast fever is a tick-borne theileriosis caused by Theileria parva, a protozoan parasite with the primary vector being the tick Rhipicephalus appendiculatus. This disease poses significant challenges in sub-Saharan Africa, leading to severe economic losses by causing the death of over one million livestock annually. Current control measures include vector control with acaricides and the "infection and treatment" method, which involves immunization with live sporozoites of the pathogen and treatment with long acting oxytetracycline. Despite their effectiveness, these methods face scalability and usability issues, necessitating the development of new prevention strategies, particularly in the field of vaccines for the effective and sustainable control of East Coast fever. In this primer focus, East Coast fever serves as a case study to highlight recent concepts and advancements in tick and tick-borne disease vaccine research. Vaccine design and evaluation processes are reviewed, encompassing the utilization of omics datasets and knowledge on vectors and pathogens, and exploring new design methods, such as quantum vaccinomics and messenger RNA (mRNA)-based vaccines. Key limitations and areas requiring further research are addressed, including insufficient understanding of host-pathogen molecular interactions, the impact of post-translational modifications, and vaccine efficacy variability across different trials. Additionally, new research objectives are proposed to address East Coast fever but with possible impact on other tick-borne diseases. It includes advancing knowledge on tick-pathogen-host molecular interactions, studying tick microbiota, developing novel design approaches, such as combining tick and pathogen epitopes in chimeric vaccines (exemplified by the q38-p67c case), and exploring new immunological enhancers and delivery platforms., This research was supported by Junta de Comunidades de Castilla-La Mancha and FEDER [Grant PROBIOHEALTH SBPLY/23/180225/000086], Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER [Grant BIOGAL PID2020-116761GB-I00], and partly supported by 2022-GRIN-34227 grant funded by the University of Castile-La Mancha and FEDER. I. Sobrino is supported by NextGenerationEU, Programa INVESTIGO-CSIC-072024001327., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tick salivary proteome and lipidome with low glycan content correlate with allergic type reactions in the zebrafish model

  • Vaz Rodrigues, Rita
  • Mazuecos, Lorena
  • Villar, Margarita
  • Contreras, Marinela
  • González-García, Almudena
  • Bonini, Paolo
  • Scimeca, Ruth C.
  • Mulenga, Albert
  • Fuente, José de la
Ticks, as hematophagous ectoparasites, can manipulate host immune and metabolic processes, causing tick-borne allergies such as α-Gal syndrome (AGS). Glycolipids with bound galactose-alpha-1–3-galactose (α-Gal) are potential allergenic molecules associated with AGS. Nevertheless, proteins and lipids lacking α-Gal modifications may contribute to tick salivary allergies and be linked to AGS. In this study, we characterized the effect of deglycosylated tick salivary proteins without lipids on treated zebrafish fed with dog food formulated with mammalian (beef, lamb, pork) meat by quantitative proteomics analysis of intestinal samples. The characterization and functional annotations of tick salivary lipids with low representation of glycolipids was conducted using a lipidomics approach. Results showed a significant effect of treatment with saliva and saliva deglycosylated protein fraction on zebrafish abnormal or no feeding (p < 0.005). Treatment with this fraction affected multiple metabolic pathways, defense responses to pathogens and protein metabolism, which correlated with abnormal or no feeding. Lipidomics analysis identified 23 lipid classes with low representation of glycolipids (0.70% of identified lipids). The lipid class with highest representation was phosphatidylcholine (PC; 26.66%) and for glycolipids it corresponded to diacylglycerol (DG; 0.48%). Qualitative analysis of PC antibodies revealed that individuals bitten by ticks were more likely to produce PC-IgG antibodies (p < 0.001). DG levels were significantly higher in tick salivary glands (p < 0.05) compared with tick saliva and salivary fractions. The α-Gal content was higher in tick saliva than in deglycosylated saliva and lipid fractions. These results support a possible role for tick salivary proteins and lipids without α-Gal modifications in AGS., We thank David Fernández (SaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Spain) for his support with the zebrafish facility and Jindřich Chmelař and Petr Kopáček (University of South Bohemia and Biology Centre, Czech Academy of Sciences, Czechia) for providing semi-engorged I. ricinus female ticks. This research was funded by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761 GB-I00). R. Vaz-Rodrigues was supported by a doctoral contract (2022/20675), from Universidad de Castilla-La Mancha (UCLM), Spain, co-financed by the European Social Fund (ESF). L. Mazuecos was funded by UCLM, co-financed by ESF (post-doctoral Grant 2021/32002). M. Contreras has received research support from the Ministerio de Ciencia, Innovación y Universidades, Spain (post-doctoral Grant IJC2020-042710-I). Paolo Bonini works at oloBion SL (Barcelona, Spain) which provided the lipidomics service., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Zebrafish gut microbiota composition in response to tick saliva biomolecules correlates with allergic reactions to mammalian meat consumption

  • Díaz-Sánchez, Sandra
  • Vaz Rodrigues, Rita
  • Contreras, Marinela
  • Rafael, Marta
  • Villar, Margarita
  • González-García, Almudena
  • Artigas-Jerónimo, Sara
  • Gortázar, Christian
  • Fuente, José de la
The α-Gal syndrome (AGS) is an IgE-mediated tick borne-allergy that results in delayed anaphylaxis to the consumption of mammalian meat and products containing α-Gal. Considering that α-Gal-containing microbiota modulates natural antibody production to this glycan, this study aimed to evaluate the influence on tick salivary compounds on the gut microbiota composition in the zebrafish (Danio rerio) animal model. Sequencing of 16 S rDNA was performed in a total of 75 zebrafish intestine samples, representing different treatment groups: PBS control, Ixodes ricinus tick saliva, tick saliva non-protein fraction (NPF), tick saliva protein fraction (PF), and tick saliva protein fractions 1–5 with NPF (F1–5). The results revealed that treatment with tick saliva and different tick salivary fractions, combined with α-Gal-positive dog food feeding, resulted in specific variations in zebrafish gut microbiota composition at various taxonomic levels and affected commensal microbial alpha and beta diversities. Metagenomics results were corroborated by qPCR, supporting the overrepresentation of phylum Firmicutes in the tick saliva group, phylum Fusobacteriota in group F1, and phylum Cyanobacteria in F2 and F5 compared to the PBS-control. qPCRs results at genus level sustained significant enrichment of Plesiomonas spp. in groups F3 and F5, Rhizobium spp. in NPF and F4, and Cloacibacterium spp. dominance in the PBS control group. This study provides new results on the role of gut microbiota in allergic reactions to tick saliva components using a zebrafish model of AGS. Overall, gut microbiota composition in response to tick saliva biomolecules may be associated with allergic reactions to mammalian meat consumption in AGS., This work was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER [grant BIOGAL PID2020-116761 GB-I00]. R. Vaz-Rodrigues was funded by the Universidad de Castilla-La Mancha (UCLM), Spain, and the European Social Fund (ESF) [doctoral contract 2022-PRED-20675]. M. Contreras was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain [post-doctoral grant IJC2020-042710-I]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30

  • Semper, Amanda E.
  • Fuente, José de la
Personal View: et al., Crimean–Congo haemorrhagic fever (CCHF) is a widely distributed and potentially fatal tick-borne viral disease with no licensed specific treatments or vaccines. In 2019, WHO published an advanced draft of a research and development roadmap for CCHF that prioritised the development and deployment of the medical countermeasures most needed by CCHF-affected countries. This Personal View presents updated CCHF research and development priorities and is the product of broad consultation with a working group of 20 leading experts in 2023–24. The strategic goals, milestones, and timelines have been revised and expanded to reflect scientific advances since 2019, including the identification of antibodies with therapeutic potential and the progression of four vaccine candidates through phase 1 clinical trials. This update emphasises the need for a One Health approach to manage CCHF, from integrated cross-sectoral surveillance to novel interventions that target ticks and their vertebrate hosts to reduce CCHF virus transmission to humans. The overarching vision for rapid diagnostics and specific therapeutics by 2028, followed by options to limit CCHF virus transmission and control disease by 2030, is deliberately ambitious and will only be achieved through coordinated international action from affected countries, funders, scientists, product developers, manufacturers, regulators, national authorities, and policy makers., JF declares a grant from the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación, Spain (grant number MCIN/ AEI/10.13039/501100011033) and the EU–European Regional Development Fund (grant number BIOGAL PID2020–116761GB-I00). JF has also received support from the Federal University of Uberlândia and the Brazilian Federal Foundation for Support and Evaluation of Graduate Education (grant number 88887.936876/2024–00) to attend the 2024 Annual Scientific Meeting of the European Veterinary Parasitology College at the University of Agronomic Sciences and Veterinary Medicine, Bucharest, Romania. TF declares funding (paid to his institution) from GuardRX (not-for-profit) and the Pandemic Institute (Liverpool) for the UMIT-1 phase 1b Crimean–Congo haemorrhagic fever (CCHF) therapeutics trial in Türkiye; from the Medical Research Council (MRC) for the UMIT-2 phase 2b CCHF therapeutics trial in Türkiye and Iraq; from the MRC for the GeneDrive PCR platform and for development of a CCHF lateral flow test. SG has received grants (paid to his institution) from the German Research Foundation, European Commission, German Government, Coalition for Epidemic Preparedness Innovations (CEPI), and Kirmser Foundation; and has received speaker honoraria and support for attending meetings from WHO and CEPI. RH is in receipt of grant funding from the Biotechnology and Biological Sciences Research Council, the Defense Threat Reduction Agency, and the MRC to investigate CCHF virus genome reassortment, sequence CCHF virus variants, and develop diagnostics for low-resource settings; and is an investigator in the EU H2020-funded CCHFVaccine project. RH is a named inventor on a patent (PCT/GB2013/0503174; WO 2014/132013) for a vectored CCHF vaccine. GKob received federal funding from the Canadian Institute for Health Research to develop immunogens based on CCHF glycoproteins (2016–21), is an inventor on a patent for CCHF virus immunogenic compositions, and received funding from Université Laval and GUARDRx (not-for-profit) to attend meetings related to the original CCHF Research and Development (R&D) Roadmap (2018–20). AC, PCF, PJH, and JPG worked at the Wellcome Trust during the time that the CCHF Roadmap was being revised and this Personal View was written. TJGB, AES, and JW received support from WHO to attend meetings related to the original CCHF R&D Roadmap (2018–20). TJGB, AES, JW, and JO received funding from the Wellcome Trust (grant number 226729/Z/22/Z) to coordinate the 2023–24 update to the CCHF R&D Roadmap and to complete this Personal View. In addition, the Wellcome Trust covered convening costs for TJGB, AES, JW, VB, M-PP, LHB, TF, PBHF, SG, RH, BJ, JF, GP, AP, and HS to attend a meeting of the CCHF working group in London, UK (Feb 13–14, 2023). A, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics

  • Sobrino, Isidro
  • Villar, Margarita
  • Fuente, José de la
Editorial., Ongoing research addressed in this article is supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain, and EU-FEDER [Grant BIOGAL PID2020-116761GB-I00], and Junta de Comunidades de Castilla-La Mancha and FEDER [grant PROBIOHEALTH SBPLY/23/180225/000086]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Is Zebrafish a good model for the alpha-Gal syndrome?

  • Vaz Rodrigues, Rita
  • Fuente, José de la
The alpha-Gal syndrome (AGS) is an underdiagnosed tick-borne allergy characterized by both immediate and delayed IgE-mediated anaphylactic reactions to the galactose-alpha-1,3-galactose (alpha-Gal) epitope. Common manifestations include gastrointestinal, cutaneous, and respiratory symptoms appearing 2–6 h after the consumption of mammalian meat or derived products. Zebrafish (Danio rerio) are emerging as essential animal models in biomedical studies, due to their anatomical, genetic, and physiological similarities to humans, with significant applications in toxicology, behavioral research, oncology, and inflammation studies. The mechanisms associated with AGS are sustained by studies in the humanized α1,3GalT-KO C57BL/6 mouse (Mus musculus) and zebrafish animal models for the production of anti-alpha-Gal antibodies in response to tick saliva, the development of allergic reactions in animals sensitized with tick protein extracts following mammalian meat consumption, and the identification of immune mechanisms. The immune mechanisms characterized in both models are associated with a skewed type 2 immune response, triggering Toll-Like receptor (TLR) signaling pathways, IL-4 production, and humoral activity. These results support the use of both models rather than a single one for a more comprehensive characterization of AGS-associated immune mechanisms. In this study, we focused on the use of zebrafish as a model for biomedicine research in immunity, infectious, and allergic diseases, with a particular emphasis on the AGS and the identification of candidate therapeutic interventions. Based on insights from multiple studies, we concluded that zebrafish is a suitable model for studying the AGS, considering the addressed limitations and in combination with the α1,3GalT-KO mouse model., This work was supported by Ministerio de Ciencia e Innovación (MCIN) (MCIN/AEI/10.13039/501100011033, EU-FEDER, BIOGAL PID2020-116761GB-I00) and Universidad de Castilla-La Mancha (UCLM) (2022-GRIN-34227). Rita Vaz-Rodrigues was funded by UCLM and the European Social Fund (ESF) [doctoral contract 2022-PRED-20675]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Allergic reactions associated with tsetse fly bites

  • Vaz Rodrigues, Rita
  • Odyek Abila, Patrick P.
  • Kasaija, Paul D.
  • Kibuuka, Moses
  • Fuente, José de la
The data obtained for the study are included in the article. Further inquiries can be directed to the corresponding author., [Background] Allergic reactions in response to arthropod bites are a growing concern worldwide. Alpha-Gal syndrome (AGS) is a red meat allergy associated with IgE antibodies against galactose-alpha-1,3-galactose (alpha-Gal), typically linked to tick bites but other arthropods may also play a role. The objective of this study was to investigate the potential association between tsetse fly (Glossina spp.) bites and AGS by analyzing clinical cases, citizen science data, and the possible production of alpha-Gal by tsetse flies., [Methods] Data from five case series involving tsetse fly bites included demographic information such as age, gender and geographical location, as well as clinical details like symptoms and diagnosis. The production of alpha-Gal by tsetse flies focused on epitope content analysis by ELISA and the expression of several galactosyltransferases using RT-qPCR in the whole body of Ugandan Glossina fuscipes fuscipes tsetse flies and midgut tissues., [Results] The cases included patients bitten by tsetse flies in Uganda–Rwanda and, with different symptoms. Individuals resided in Spain, the USA or Uganda, with no record of or reaction to bites from ticks or other arthropods. Cases 1 and 2 were diagnosed with AGS, whereas Ugandan Case 3 presented symptoms consistent with AGS. Ugandan participative or citizen science survey identified one individual (Case 4) who experienced allergic reactions to red meat following multiple tsetse fly bites, while eight individuals (summarized as grouped Case 5) exhibited only local skin reactions to several bites. The expression of galactosyltransferases suggested the possible production of alpha-Gal modification in these arthropods., [Conclusion] Allergic anaphylactic reactions to tsetse fly bites may occur in some individuals, potentially linking tsetse fly bites to AGS. Diagnosis and monitoring should consider factors beyond anti-alpha-Gal IgE antibody levels, such as arthropod salivary compounds and human immune biomarkers., The submitted work was partially supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (Grant BIOGAL PID2020-116761GB-I00). R. Vaz-Rodrigues was supported by a doctoral contract (2022/20675), from Universidad de Castilla-La Mancha (UCLM), Spain, co-financed by the European Social Fund (ESF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Public perspectives on tick bite exposure, healthcare visits and associated allergies in iberia

  • Vaz Rodrigues, Rita
  • Rafael, Marta
  • Carniato, Davide
  • Fuente, José de la
[Background] Tick bites and tick-borne diseases (TBDs) are a worldwide concern, with growing evidence of an ongoing spread and emergence of new cases. This study applied a participatory citizen science across Spain and Portugal to gather public perspectives on the impact of tick bites, the presence of TBDs and a potential connection with the α-Gal syndrome (AGS)., [Methods] Data collected from the questionnaire (380 participants) was geographically represented using QGIS Geographic Information System and fitted into multiple generalized linear models (GLMs). Statistical analysis identified factors influencing the occurrence of local skin reactions post-tick bite, AGS-compatible symptoms and visits to health centers following tick exposure., [Results] Results showed that the probability of developing localized skin reactions to tick bites rises with increasing age (χ2 = 0.006, p < 0.05), the occurrence of multiple bites (χ2 = 0.006, p = 0.063) and among individuals bitten in the center-north part of the peninsula (χ2 = 0.006, p = 0.058). Seeking medical care following tick bite was reported by 21.6% of respondents, being more common in first-time bite cases (χ2 = 0.002, p < 0.01), men (χ2 = 0.002, p < 0.01) or individuals presenting localized skin symptoms (χ2 = 0.002, p < 0.05). Although 38 inquiries (10.0%) showed signs of AGS, only 3 had received a formal diagnosis, with the odds of developing this disease marginally rising with advancing age (χ2 = 0.215, p = 0.066)., [Conclusions] This study provides valuable insights that should be considered to improve TBDs surveillance and diagnostic strategies, as well as developing preventive measures to reduce tick bite exposure and TBD cases., This work was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER under Grant BIOGAL PID2020-116761GB-I00). R. Vaz-Rodrigues was supported by a doctoral contract (2022/20675), from Universidad de Castilla-La Mancha (UCLM), Spain, co-financed by the European Social Fund (ESF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Identification and characterization of tick salivary biomolecules and mechanisms associated with the immune response to alpha-Gal, Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a alpha-Gal

  • Vaz Rodrigues, Rita
Trabajo de investigación presentado por Rita Vaz Rodrigues para optar al grado de Doctora con mención internacional por la Universidad de Castilla-La Mancha. Programa de Doctorado en Ciencias Agrarias y Ambientales. Instituto de Investigación en Recursos Cinegéticos (IREC, CSIC-UCLM-JCCM). Grupo SaBio – Sanidad y Biotecnología Departamento de Ciencia y Tecnología Agroforestal y Genética., [EN] The alfa-Gal syndrome (AGS) is characterized by an immunoglobulin (Ig)E-mediated type I delayed hypersensitivity reaction to the oligosaccharide galactose-alpha-1,3-galactose (alpha-Gal). Old-World monkeys, apes and humans evolved with the inability to synthesize alpha-Gal epitopes, thus producing natural anti-alpha-Gal antibodies when exposed to this moiety, normally in response to gut bacteria or pathogen infection. Initial IgE sensitization is primarily attributed to alpha-Gal bound to tick salivary glycoproteins or glycolipids, however other biomolecules without alpha-Gal modifications may also play a role. Evidence shows that bites from hard-bodied tick species such as Ixodes ricinus in Europe, Amblyomma americanum in North America, Haemaphysalis longicornis in Asia, and Ixodes holocyclus in Australia act as triggers for AGS. Clinically, AGS is a shapeshifter, with symptoms ranging from delayed anaphylaxis to gastrointestinal, cutaneous, and respiratory manifestations that occur two to six hours after the consumption of alpha-Gal-containing foods or pharmaceuticals. Previous studies have primarily focused on uncovering the global immunological effects of tick saliva at sensitization site and associated serological changes, leaving gaps in understanding which specific tick salivary biomolecules trigger IgE sensitization. Animal models play a crucial role in advancing biomedical research by providing insights into pathological and biological processes. Due to their functional and genetic homology with humans, zebrafish (Danio rerio) represent a relevant model to study allergic reactions and immune mechanisms triggered by tick salivary substances and mammalian meat consumption. Additionally, progressing from zebrafish to a humanized mouse model for AGS pathogenesis studies increases translational value due to greater physiological and immunological similarity to humans. Accordingly, the murine model was engineered by knockout of the gene α-1,3-galactosyltransferase (α1,3GalT-KO) on a C57BL/6 background. The present doctoral thesis aimed to identify and characterize the role of tick salivary biomolecules in AGS and related allergic responses by integrating in vitro and in vivo models and applying a multi-omics approach. Additionally, clinical cases were incorporated to investigate the role of other arthropod bites in AGS onset, while public perceptions of tick bites and AGS were also assessed., [ES] El síndrome alfa-Gal (SAG) se caracteriza por una reacción de hipersensibilidad retardada de tipo I mediada por la inmunoglobulina E (IgE) frente al oligosacárido galactosa-alfa-1,3-galactosa (alfa-Gal). Los monos del Viejo Mundo, los simios y los humanos evolucionaron sin la capacidad de sintetizar epítopos de alfa-Gal, lo que conlleva la producción natural de anticuerpos anti-alfa-Gal tras la exposición a esta molécula, normalmente en respuesta a bacterias intestinales o agentes patogénicos. La sensibilización inicial de tipo IgE se atribuye principalmente al alfa-Gal unido a glicoproteínas o glicolípidos salivales de garrapata. Sin embargo, otras biomoléculas sin modificaciones de alfa-Gal también podrían estar implicadas. La evidencia indica que las picaduras de garrapatas duras, como Ixodes ricinus en Europa, Amblyomma americanum en América del Norte, Haemaphysalis longicornis en Asia e Ixodes holocyclus en Australia, actúan como desencadenantes del SAG. Clínicamente, el SAG presenta un perfil camaleónico, con síntomas que van desde anafilaxia retardada hasta manifestaciones gastrointestinales, cutáneas y respiratorias que ocurren entre dos y seis horas tras el consumo de alimentos o fármacos que contienen alfa-Gal. Estudios previos se han centrado en los efectos inmunológicos de la saliva de garrapata en el sitio de sensibilización y en los cambios serológicos asociados, dejando lagunas sobre qué biomoléculas salivales desencadenan la sensibilización mediada por IgE. Los modelos animales desempeñan un papel crucial en el avance de la investigación biomédica al proporcionar información sobre procesos patológicos y biológicos. Debido a su homología funcional y genética con los humanos, el pez cebra (Danio rerio) representa un modelo relevante para estudiar las reacciones alérgicas y los mecanismos inmunológicos desencadenados por componentes salivales de garrapatas y el consumo de carne roja. Además, la transición del pez cebra a un modelo murino humanizado para estudiar la patogénesis del SAG incrementa el valor traslacional, ya que ofrece una mayor similitud fisiológica e inmunológica con los seres humanos. En consecuencia, este modelo murino fue desarrollado mediante la inactivación del gen de la alfa-1,3-galactosiltransferasa (α1,3GalT-KO) en un fondo genético C57BL/6. La presente tesis doctoral tuvo como objetivo identificar y caracterizar el papel de biomoléculas salivales de garrapata en el SAG y en respuestas alérgicas relacionadas, integrando modelos in vitro e in vivo y aplicando un enfoque multi-ómico. Además, se incorporaron casos clínicos para investigar el papel de otras picaduras de artrópodos en el desencadenamiento del SAG, y se evaluaron percepciones públicas sobre las picaduras de garrapata y el SAG., La presente tesis doctoral ha sido financiada por las siguientes entidades: Universidad de Castilla-La Mancha (UCLM): Contrato predoctoral (2022-PRED-20675) para la formación de personal investigador en el marco del Plan Propio de I+D+i de la UCLM, cofinanciado por el Fondo Social Europeo (FSE+), resolución de febrero de 2022. Ministerio de Ciencia, Innovación y Universidades: Proyectos I+D+i – modalidades retos investigación y generación de conocimiento, convocatoria 2020, “Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a α-Gal (BIOGAL)”, con referencia administrativa PID2020-116761GB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcriptomics insights into the functional role of tick Ixodes ricinus proteins metalloprotease and antigen p23

  • Vaz Rodrigues, Rita
  • Duru, Vincent C.
  • Nijhof, Ard M.
  • Fuente, José de la
Data Availability: All data associated with this study are included in the paper or its supplementary information. Transcriptomics data was deposited in the NCBI Gene Expression Omnibus (GEO) database, under the GEO series accession no. GSE291137., Ixodes ricinus ticks (Acari: Ixodidae) are hematophagous ectoparasites and a major European vector of zoonotic diseases affecting global health. Tick salivary and midgut proteins antigen p23 (A0A0K8RKR7) and metalloprotease (A0A0K8RCY8) were previously implicated in the pathophysiology of the tick-borne allergy alpha-Gal syndrome (AGS). This study aimed to functionally characterize these two biomolecules, focusing on their role in I. ricinus tick feeding and reproduction through gene knockdown by RNA interference and midgut transcriptomic analysis. Validation of RNA-seq data was conducted using RT-qPCR analysis on tick midgut and salivary gland tissues. Silencing the expression of p23 and metalloprotease did not result in any significant differences in tick engorgement and egg batch weights compared to the control group. Gene set enrichment analysis following antigen p23 gene knockdown identified significantly upregulated pathways associated with protein production and suppressed routes mostly correlated with ion transport, lipid metabolism, catalytic activity, protein modification, and G-protein activity. Partial knockdown of the metalloprotease led to the upregulation of several biological and functional pathways associated with RNA splicing and significantly suppressed routes connected with detoxification, protein modification, catalytic activity and molecule binding. Antigen p23 appears to play a functional role in tick midgut cell homeostasis, primarily by participating in regulatory and signaling processes essential for cell viability. Metalloprotease is potentially involved in regulating midgut response to oxidative stress, thereby reducing tissue damage and promoting regular cell proliferation, growth and behavior. These results provide insights into tick physiology and bases for further research on tick-host interactions and AGS pathogenesis., This work was supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Spain and EU-FEDER (grant BIOGAL PID2020-116761GB-I00). R. Vaz-Rodrigues was funded by Universidad de Castilla-La Mancha (UCLM), Spain and the European Social Fund (ESF) (doctoral contract 2022-PRED-20675). Vincent C. Duru was funded by the Berlin University Alliance (BUA) under the Grand Challenge Global Health initiative (grant 113_MC_GH_MEL-BER_Nijhof_FU)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Characterization of the immune response to alpha-gal antigen and possibilities for the control of infectious diseases, Caracterización de la respuesta inmune frente al antígeno alfa-Gal y posibilidades para el control de enfermedades infecciosas

  • Pacheco, Iván
Trabajo de investigación presentado por Iván Pacheco Carrillo para optar al grado de Doctor por la Universidad de Castilla-La Mancha., [EN] Ticks are blood-feeding arthropod ectoparasite vectors of pathogens affecting human and animal health worldwide by increasing the prevalence of infectious diseases and allergic reactions such as the Alpha-Gal Syndrome (AGS). Actually, tick-borne pathogens (TBPs) implicated in infestations and disease development are controlled mainly using chemical acaricides, with the harmful causes they generate on the environment and the selection of resistant ticks. Vaccines are considered the most effective and eco-sustainable solution to control pathogen infection, multiplication and transmission, which is why omics technologies and bioinformatic tools have been optimized at the molecular and physiological level, identifying possible candidate protective antigens. This doctoral thesis focuses on the characterization of the role of the carbohydrate alpha-Gal in vector-host-pathogen molecular interactions and the AGS. The results support alpha-Gal as candidate antigen to develop vaccines for the control of major infectious diseases and reduce the use of acaracides in support of the One Health approach., [ES] Las garrapatas son ectoparásitos artrópodos que se alimentan de sangre. Actúan como vectores de patógenos, afectando la salud humana y animal por todo el mundo al aumentar la prevalencia de enfermedades infecciosas y reacciones alérgicas como es el síndrome de alfa-Gal (AGS). Actualmente, los patógenos transmitidos por garrapatas (TBPs) implicados en infestaciones y desarrollo de enfermedades son controlados principalmente mediante acaricidas químicos, con los efectos nocivos que éstos pueden generar tanto sobre el medio ambiente, como por la selección de garrapatas resistentes. Las vacunas son consideradas como la solución más eficaz y ecosostenible para controlar la infección, multiplicación y transmisión de patógenos, por lo que las tecnologías ómicas y herramientas bioinformáticas se han optimizado a nivel molecular y fisiológico, identificando posibles candidatos como antígenos protectores. Esta tesis doctoral se centra en la caracterización del papel del carbohidrato alfa-Gal en las interacciones moleculares vector-hospedador-patógeno y el AGS. Los resultados respaldan como antígeno candidato a la molécula de alfa-Gal para el desarrollo de vacunas para el control de las principales enfermedades infecciosas y, con ello, reducir el uso de acaricidas en apoyo del concepto de “Una Salud”., La realización de esta tesis ha sido posible gracias a las siguientes entidades y proyectos: Consejería de Educación, Cultura y Deportes, JCCM: proyecto CCM17-PIC-036 (SBPLY/17/180501/000185) cofinanciado por parte de la Junta de Castilla-La Mancha y del Fondo Europeo de Desarrollo Regional (FEDER), respetando lo dispuesto en el anexo XII del reglamento (UE) 1303/2013. Ministerio de Ciencia e Innovación: Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a alpha-Gal (BIOGAL); PID2020-116761GB-I00., Peer reviewed